Alterity Therapeutics (PRNAD) Restructuring Costs (2010 - 2025)

Alterity Therapeutics (PRNAD) has reported Restructuring Costs for 8 consecutive years, with $300347.2 the latest figure, recorded in Q4 2025.

• In Q4 2025, Restructuring Costs rose 1.98% year-over-year to $300347.2; the TTM figure through Dec 2025 stood at $880752.6 (up 23.47% YoY), while the FY2024 annual figure was $520.9 billion, up 70.45% from the prior year.
• Restructuring Costs came in at $300347.2 for Q4 2025 at Alterity Therapeutics, up from $294528.3 in the prior quarter.
• The five-year high for Restructuring Costs was $300347.2 in Q4 2025, with the low at $126118.3 in Q4 2023.
• Average Restructuring Costs over 4 years is $220188.2, with a median of $227143.6 recorded in 2024.
• Across the five-year window, Restructuring Costs slipped 21.06% in 2023 and soared 133.53% in 2024, its largest moves.
• Year by year, Restructuring Costs stood at $159758.8 in 2022, then retreated by 21.06% to $126118.3 in 2023, then jumped by 133.53% to $294528.3 in 2024, then increased by 1.98% to $300347.2 in 2025.
• According to Business Quant data, Restructuring Costs over the past three periods registered $300347.2, $294528.3, and $126118.3 for Q4 2025, Q4 2024, and Q4 2023 respectively.